Estatistikak
Guztirako bisita-kopurua
| Bisita-kopurua | |
|---|---|
| 1484 Evaluating local failure in lung cancer post-SBRT: the role of SUVmax | 511 |
Hilabeteko bisita-kopurua
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|
| 1484 Evaluating local failure in lung cancer post-SBRT: the role of SUVmax | 34 | 53 | 101 | 42 | 13 | 16 |
| January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | |
|---|---|---|---|---|---|---|
| 1484 Evaluating local failure in lung cancer post-SBRT: the role of SUVmax | 15 | 7 | 20 | 47 | 60 | 25 |
| July 2026 | August 2026 | |
|---|---|---|
| 1484 Evaluating local failure in lung cancer post-SBRT: the role of SUVmax | 50 | 28 |
Fitxategiaren deskargak
| Bisita-kopurua | |
|---|---|
| 2024_RadiationOncology_Abstract_Evaluating _SUVmax.pdf | 161 |
Bisita gehien egiten diren herrialdeak
| Bisita-kopurua | |
|---|---|
| United States | 268 |
| China | 72 |
| Vietnam | 22 |
| United Kingdom | 17 |
| Argentina | 10 |
| Japan | 10 |
| Brazil | 8 |
| Spain | 8 |
| France | 8 |
| Mexico | 6 |
Bisita gehien egiten diren hiriak
| Bisita-kopurua | |
|---|---|
| Mountain View | 21 |
| Buffalo | 15 |
| San Jose | 10 |
| Los Angeles | 7 |
| Beijing | 5 |
| Singapore | 5 |
| Madrid | 4 |
| Ashburn | 3 |
| Chanshan | 3 |
| Glen Iris | 3 |





